Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus

Oct.26.2022
Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus
Advocates call for ban on flavored tobacco products in Columbus stores to address marketing targeting vulnerable communities.

Health advocates are urging the Columbus City Council to ban the sale of menthol cigarettes and flavored electronic cigarettes in stores throughout the city.


Amanda Turner, the Executive Director of Tobacco 21, stated that the city council has not yet proposed any legislation, but the proposal is currently being drafted. Turner explained that this issue first arose approximately 18 months ago during a conversation with the Columbus Department of Public Health.


Dr. Phillip Gardner, a public health expert, has stated that 85 cities in the United States have already banned the sale of menthol cigarettes and flavored e-cigarettes, with an additional 300 cities recently banning the sale of flavored e-cigarettes. Gardner, who is co-chair of the African American Tobacco Control Leadership Council, also noted that Canada has a nationwide ban on the sale of menthol cigarettes.


Gardner and Turner stated that prohibiting the sale of these products in the city will begin to reverse the effects of decades of marketing aimed specifically at black people, other people of color, women, LGBTQ individuals, and other marginalized groups. Gardner said that the industry profits by using "disproportionate marketing and predatory plunder" to exploit vulnerable communities and make a profit.


According to him, tobacco marketers have discovered that promoting menthol cigarettes to black celebrities and athletes, even lowering their costs in communities with African Americans. Currently, 85% of black smokers use menthol cigarettes, while the same figure for white smokers is 30%. "In the early 1950s, only 5% of African Americans smoked menthol cigarettes. By 1968, this percentage had almost tripled to 14%. By 1976, it had tripled again to 42%," Gardner said.


He stated that despite critics suggesting that such a ban would only create an illegal market or push shoppers to other jurisdictions, the data indicates that this has not been the case in these areas. Turner further explained that the data shows that removing more addictive tobacco from the equation would aid individuals in quitting smoking.


Many individuals may switch products, but research indicates that if you are using menthol cigarettes and wish to quit smoking and switch to regular cigarettes, your chances of successfully quitting are higher because menthol is a flavoring. It is a cooling agent that can suppress coughing, Turner explained.


Gardner stated that this is "outrageous" because adding menthol makes people more susceptible to nicotine addiction and more difficult to quit. "Menthol is defined as an anesthetic that actually covers up the harsh taste of tobacco smoke. It has a numbing and cooling effect and allows for deeper inhalation. The deeper you inhale, the more toxins and nicotine you ingest," Gardner said. "The more nicotine and toxins you ingest, the more addicted you become. Quitting becomes even harder. That's why they put it in there. It's outrageous from the start.


Gardiner stated that the FDA is currently exploring the idea of banning the use of menthol in cigarettes, but the process would take too long. "The FDA is considering getting rid of menthol, but unfortunately, due to the FDA's delay, it is important for communities like Columbus to take action themselves. The FDA will need several years to accomplish this," he said.


Turner and Gardner stated that the ban would not prohibit products within the city, but only the sale of them. Therefore, individuals would not face trouble for purchasing and bringing them in from elsewhere. "These laws are about getting retailers to stop selling them and not about individuals using personal property or pursuing a percentage," said Gardner.


Critics say the ban is unfair to smokers who enjoy menthol or use flavored e-cigarettes as an alternative to traditional cigarettes. Some argue that it discriminates against Black smokers. In response, Gardner stated that "racists are not public health doctors, they're in the tobacco industry." "Indeed, it has been the tobacco industry that has been discriminatory, that has been racist," Gardner continued. "It is not the tobacco control movement that is trying to save lives.


When asked why health officials are taking action to prevent flavored tobacco instead of flavored alcohol, Gardner explained that occasional alcohol consumption, not including binge drinking, does not kill people. However, "if you use cigarettes as expected, 50% of people will die from smoking.


Cigarettes are more deadly. In fact, tobacco-related diseases are the leading cause of death in the world, including in the United States, Ohio, and unfortunately Columbus. This is the reality. We are working hard to save lives," Gardner said.


Art Way, a drug policy consultant who works with the tobacco industry, argues that focusing on smoking cessation is a more effective way to reduce nicotine addiction. Targeted bans like these, Way contends, are similar to "patronizing, drug war-type policies that do not benefit our communities.


Statement:


This article is based on compiled third-party information and is only intended for intra-industry communication and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is solely for industry research and communication purposes.


Due to limitations in translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan or foreign-related expressions and perspectives.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom heated-tobacco volumes rose 43.5% in the first half of 2026, while combustibles still represented about 97% of its tobacco volume and remained the main earnings base. In Japan, reduced-risk products now account for 48.7% of industry shipments, shifting competition from category adoption towards brand share, pricing and consumer retention. JT’s results offer a revealing case of a traditional tobacco company pursuing a prolonged, dual-track transformation.
JTI
Jul.30
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives